The association between PM2.5 and frailty: evidence from 122 cities in China and 7 countries in Europe
- PMID: 39736606
- PMCID: PMC11684102
- DOI: 10.1186/s12889-024-21121-4
The association between PM2.5 and frailty: evidence from 122 cities in China and 7 countries in Europe
Abstract
Background: The accelerated aging process worldwide is placing a heavy burden on countries. PM2.5 particulate matter exposure is a significant factor affecting human health and is crucial in the aging process.
Methods: We utilized data from China Health and Retirement Longitudinal Study (CHARLS) and the Survey of Health, Aging, and Retirement in Europe (SHARE) to study the relationship between PM2.5 exposure and the frailty index. Acquire PM2.5 exposure data for China and Europe, match them according to geographic location within the database. Our study used frailty index to evaluate frailty, which comprises 29 items. We examined the association between PM2.5 and frailty index using fixed-effects regression models and Mendelian randomization (MR) analysis.
Results: We first examined the association between PM2.5 and frailty index using fixed-effects regression models, revealing a notable positive link across populations in China (coefficient = 0.0003, P = 0.0380) and Europe (Coefficient = 0.0019, P < 0.0001). This suggests that PM2.5 exposure is a significant risk factor for frailty, leading to accelerated frailty. Moreover, our MR analysis uncovered a possible causal association (OR = 1.2933, 95%CI: 1.2045-1.3820, P < 0.0001) between PM2.5 exposure and the frailty index.
Conclusions: Our findings indicate that long-term exposure to PM2.5 in the environment is a risk factor for physical frailty and may have a potential causal relationship. Given the rapid global aging trend, public health measures are needed to reduce PM2.5 concentrations and prevent frailty.
Keywords: Aging; Air pollution; Cohort study; Frailty index; PM2.5.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: CHARLS received ethical approval from the Biomedical Ethics Review Committee of Peking University (IRB00001052-11015) and all participants provided informed written consent. SHARE received ethical approval from the Ethics Council of the Max Planck Society and all participants provided informed written consent. GWAS summary data and air pollution data are public data and do not require ethical approval. Consent for publication: All authors approved the final manuscript and the submission to this journal. Competing interests: The authors declare no competing interests.
Figures



References
-
- http://www.who.int/news-room/fact-sheets/detail/ageing-and-health2022; Aging and Health.
-
- Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376–86. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources